Former US President Joe Biden, aged 82, has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, marking a serious escalation in the disease. The diagnosis was made ...

About 4,500 men are diagnosed with prostate cancer in New Zealand every year, and more than 700 will die from it.

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

May 19 (Reuters) - Former U.S. President Joe Biden has been diagnosed with an "aggressive form" of prostate cancer that has spread to his bones, his office said in a statement on Sunday. Sign up here.

I was diagnosed with prostate cancer – this is what all men need to know - FIRST PERSON: A routine check led to months of ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and ...

Prostate cancer, an uncontrolled growth of cells in the prostate, a gland in the male reproductive system located below the bladder, is one of the most common cancers that affects men, especially in ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both before and after surgery for high-risk prostate cancer, significantly ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.